Upstream Bio, Inc. UPB Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $96.72M-4.8% | $101.58M+40.8% | $72.16M+58.7% | $45.46M-36.3% | $71.31M-78.1% | ||
| $197.86M-17.5% | $239.93M-20.1% | $300.26M-13.7% | $348.12M-3.3% | $360.07M+149% | ||
| $1.03M+54.8% | $668K-2.2% | $683K-27.1% | $937K+65.5% | $566K-7.7% | ||
| $316.28M-10.1% | $351.8M-9.6% | $389.02M-7.0% | $418.27M-7.8% | $453.79M-5.3% | ||
| $510K-8.8% | $559K-9.3% | $616K+13.2% | $544K+0.9% | $539K-7.4% | ||
| $318.05M-10.1% | $353.77M-9.6% | $391.2M-7.0% | $420.52M-7.8% | $456.17M-5.3% | ||
| $1.71M-37.3% | $2.73M-31.0% | $3.95M+54.9% | $2.55M-45.9% | $4.72M+16.8% | ||
| $13.67M+1.6% | $13.45M+13.0% | $11.91M+9.0% | $10.93M+14.2% | $9.57M-10.9% | ||
| $14.06M+0.4% | $14M+11.0% | $12.61M+7.1% | $11.78M+11.5% | $10.56M-11.0% | ||
| $54K0.0% | $54K-3.6% | $56K+3.7% | $54K+1.9% | $53K0.0% | ||
| -$374.81M-12.1% | -$334.22M-14.6% | -$291.76M-13.1% | -$258.02M-18.3% | -$218.05M-14.3% | ||
| $304M-10.5% | $339.77M-10.3% | $378.58M-7.4% | $408.74M-8.3% | $445.61M-5.2% | ||
| $318.05M-10.1% | $353.77M-9.6% | $391.2M-7.0% | $420.52M-7.8% | $456.17M-5.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Upstream Bio, Inc.'s total assets?
- Upstream Bio, Inc. (UPB) holds $318.1M in total assets, down 30.3% year over year.
- How much debt does Upstream Bio, Inc. have?
- Upstream Bio, Inc. carries $1.1M in total debt against $304.0M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Upstream Bio, Inc. have?
- Upstream Bio, Inc. holds $96.7M in cash and equivalents.
- Can Upstream Bio, Inc. cover its short-term obligations?
- Its current ratio is 23.14 — current assets exceed current liabilities.
- Where does Upstream Bio, Inc.'s balance sheet data come from?
- Every line is extracted from Upstream Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
